| Registry of Patients Diagnosed With Lysosomal Storage Diseases (NCT05619900) | University of California, San Francisco | 2022-05-31 |
| China Post-marketing Surveillance (PMS) Study of Aldurazyme® (NCT05134571) | Genzyme, a Sanofi Company | 2021-10-28 |
| An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I) (NCT04453085) | JCR Pharmaceuticals Co., Ltd. | 2021-10-28 |
| Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX (NCT04628871) | Sangamo Therapeutics | 2020-11-03 |
| A Study of JR-171 in Patients With Mucopolysaccharidosis I (NCT04227600) | JCR Pharmaceuticals Co., Ltd. | 2020-09-01 |
| MPS (RaDiCo Cohort) (RaDiCo-MPS) (NCT06036693) | Institut National de la Santé Et de la Recherche Médicale, France | 2017-12-20 |
| Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI (NCT03153319) | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2017-06-05 |
| Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I (NCT03071341) | ArmaGen, Inc | 2016-10-01 |
| Extension Study of AGT-181-102 to Evaluate Long Term Safety and Activity of AGT-181 (NCT02597114) | ArmaGen, Inc | 2015-11-01 |
| Safety and Dose Ranging Study of Human Insulin Receptor MAb-IDUA Fusion Protein in Adults and Children With MPS I (NCT03053089) | ArmaGen, Inc | 2015-10-01 |
| Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I (NCT02371226) | ArmaGen, Inc | 2015-07-01 |
| Extension Study of Intrathecal Enzyme Replacement for Cognitive Decline in MPS I (NCT02232477) | agnes chen | 2014-08-01 |
| Human Placental-Derived Stem Cell Transplantation (NCT01586455) | New York Medical College | 2013-04-01 |
| Study to Detect Unrecognized Mucopolysaccharidosis in Children Visiting Rheumatology, Hand or Skeletal Dysplasia Clinics (NCT01675674) | National MPS Society | 2011-09-01 |
| A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants (NCT00418821) | Genzyme, a Sanofi Company | 2010-10-22 |
| A Study of Intrathecal Enzyme Therapy for Cognitive Decline in MPS I (NCT00852358) | Patricia I. Dickson, M.D. | 2009-06-01 |
| Immune Tolerance Study With Aldurazyme® (Laronidase) (NCT00741338) | Genzyme, a Sanofi Company | 2008-09-01 |
| Extension Study of Intrathecal Enzyme Replacement Therapy for MPS I (NCT00786968) | Patricia I. Dickson, M.D. | 2008-01-01 |
| Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products (NCT00695279) | St. Jude Children's Research Hospital | 2007-01-04 |
| Study of Aldurazyme® Replacement Therapy in Patients With Mucopolysaccharidosis I (MPS I) Disease (NCT00258011) | Genzyme, a Sanofi Company | 2005-12-01 |
| Intrathecal Enzyme Replacement Therapy for Spinal Cord Compression in Mucopolysaccharidosis (MPS) I (NCT00215527) | Patricia I. Dickson, M.D. | 2005-11-01 |
| A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease (NCT00144781) | Genzyme, a Sanofi Company | 2004-12-01 |
| A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated Patients (NCT00144768) | Genzyme, a Sanofi Company | 2004-07-01 |
| Stem Cell Transplant w/Laronidase for Hurler (NCT00176891) | Masonic Cancer Center, University of Minnesota | 2004-03-01 |
| A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years Old (NCT00146757) | Genzyme, a Sanofi Company | 2002-10-01 |
| Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients (NCT00146770) | Genzyme, a Sanofi Company | 2001-05-01 |
| Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) I (NCT00912925) | Genzyme, a Sanofi Company | 2000-12-01 |
| Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (NCT00005900) | Fairview University Medical Center | 1999-08-01 |
| Stem Cell Transplantation for Hurler (NCT00176917) | Masonic Cancer Center, University of Minnesota | 1999-05-01 |